Emergent BioSolutions says it will donate 50,000 doses of its ACAM2000 smallpox vaccine to help against the mpox outbreak in Africa. According to Emergent, the FDA is presently reviewing a supplemental Biologics License Application (sBLA) to expand ACAM2000’s indication to include mpox immunization. The company expects the FDA to complete its review in the third…